This comprehensive text defines and addresses the broad spectrum of acute and chronic internal medicine disorders that occur in cancer patients and cancer survivors as side effects of the disease itself, or from treatment regimens.With the development of highly effective antiemetics such as the 5-HT3 antagonists, the opposite pattern is now seen: there is often complete ... The NCCN guidelines offer that palonosetron may be used before the start of a multiple-day chemotherapy regimen. ... For the high-risk category (agt;90% risk), MASCC and ASCO guidelines recommend prophylaxis with 5-HT3 antagonists plus dexamethasone.
|Title||:||Internal Medical Care of Cancer Patients|
|Publisher||:||PMPH-USA - 2007-03|